Northwestern Medicine scientists have developed a new tool to help physicians predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas, results published in the journal Blood.
Mar 17, 2023
0
42
Leukemia (blood cancer) is a group of malignant and aggressive diseases of the blood-forming cells in the bone marrow. Very intensive chemotherapy and in some cases a bone marrow transplant are the only cure. Like all cancers, ...
Mar 10, 2023
0
17
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), co-led by Professor Daniel G. Tenen and Associate Professor Polly Chen Leilei, made an unprecedented ...
Mar 8, 2023
0
7
Targeted drugs have been developed to supplement chemotherapy in the treatment of cancer. These drugs only affect cancer cells, leaving healthy cells alone. Venetoclax is a new targeted therapy option for the treatment of ...
Feb 23, 2023
0
38
The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor cells must do to survive. Researchers from the Wellcome Sanger Institute found that cancer cells ...
Feb 13, 2023
0
11
More than 10% of older adults develop somatic (non-inherited) mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells, increasing the risk for blood cancer and cardiovascular disease.
Feb 8, 2023
0
17
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have illuminated how treatments for multiple myeloma and other aggressive blood cancers can lead to future malignancies, ...
Jan 26, 2023
0
10
Medical science has not yet been able to explain why the Epstein-Barr virus triggers infectious mononucleosis (IM) in some people with initial infections and not in others. But now, a research team led by Elisabeth Puchhammer-Stöckl, ...
Jan 19, 2023
0
9
A research team led by scientists from the University of Veterinary Medicine Vienna (Vetmeduni) has taken an important step toward a better understanding of certain difficult-to-treat blood cancers. The researchers have identified ...
Jan 19, 2023
0
22
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Jan 13, 2023
0
21
